Litcius/Paper detail

Risk of malignancy with non-TNFi biologic or tofacitinib therapy in rheumatoid arthritis: A meta-analysis of observational studies

Wenhui Xie, Xinlei Yang, Hong Huang, Dai Gao, Lanlan Ji, Zhuoli Zhang

2020Seminars in Arthritis and Rheumatism48 citationsDOI

Topics & Concepts

TofacitinibMedicineRheumatoid arthritisObservational studyMalignancyMeta-analysisDermatologyTocilizumabInternal medicineAbataceptArthritisOncologyLymphomaRituximabRheumatoid Arthritis Research and TherapiesSpondyloarthritis Studies and TreatmentsAutoimmune and Inflammatory Disorders Research
Risk of malignancy with non-TNFi biologic or tofacitinib therapy in rheumatoid arthritis: A meta-analysis of observational studies | Litcius